SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-002343
Filing Date
2012-01-17
Accepted
2012-01-17 13:46:37
Documents
9
Period of Report
2011-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a12-2104_110q.htm 10-Q 321567
2 EX-31.1 a12-2104_1ex31d1.htm EX-31.1 12365
3 EX-32.1 a12-2104_1ex32d1.htm EX-32.1 8849
  Complete submission text file 0001104659-12-002343.txt   1187785

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bzyr-20111130.xml EX-101.INS 90808
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20111130.xsd EX-101.SCH 8556
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20111130_cal.xml EX-101.CAL 18724
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20111130_lab.xml EX-101.LAB 122558
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20111130_pre.xml EX-101.PRE 66844
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20111130_def.xml EX-101.DEF 44691
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 12529138
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1